Mach7 Technologies Ltd. · ASX:M7T
Mach7 Technologies — Investor Day (October 2023)
31 slides from Mach7 Technologies's investor day presentation, Oct 9, 2023
Slide 1: Mach7 Investor Day Presentation ASX Announcement
ASX Announcement 9 October 2023 MACH7 INVESTOR DAY PRESENTATION Mach7 Technologies Limited (“Mach7” or the “Company”) (ASX:M7T), a company specialising in innovative medical imaging software solutions, provides the attached presentation for the Investor Day being held today from 8.30-11am AEDT. Inve
Slide 2: Mach7 Technologies Investor Day
For personal use only Mach7 Technologies Investor Day 9 October 2023 Mach7 Technologies ASX: M7T 1
Slide 3: Disclaimer forward looking statements
Disclaimer “forward looking” statements Summary of information: This presentation contains general and background information about Mach7 Risks: An investment in M7T securities is subject to investment and other known and unknown risks, Technologies Limited (“M7T”) activities current as at the date
Slide 4: Agenda
For personal use only Agenda Welcome & Overview Mike Lampron, CEO Sales Overview David Madaffri, COO VNA Demonstration Jeff Hastings, Technical Sales Manager Clinical Demonstration Kristi Creasey, Senior Clinical Specialist Q&A 3 Unless otherwise stated, all dollar values are in Australian dollars (
Slide 5: Welcome & Overview
Welcome & Overview Mike Lampron, CEO For personal use only 4 4
Slide 6: About Mach7 Technologies (ASX:M7T)
About Mach7 Technologies (ASX:M7T) Mach7 Technologies develops innovative image For personal use only management and viewing solutions that form the core of an integrated enterprise imaging ecosystem. We give healthcare organizations the independence and flexibility to deploy our solutions according
Slide 7: Mach7 History – Key Milestones
For personal use only Mach7 History – Key Milestones Mach7 Selected Mach7 Listed on Mach7 Mach7 Acquires for Veterans the Australian Technologies Client Outlook Health Stock Exchange Founded (eUnity) Administration (ASX) Contract 2010 2018 2022 2007 2016 2020 2023 Mach7 Recognized as Mach7 Signs Fir
Slide 8: Our AI Position
Our AI Position AI Market Dynamics: AI Ready - Data Storage, Management & Orchestration For personal use only • According to Signify Research, the medical imaging AI Deployment, integration, data depth, data management and market was estimated at US$576 million and is forecast to data orchestration
Slide 9: Our Customer Composition
Our Customer Composition Customer & Product Profile1 ClientOutlook Acquisition Impact $25.0 For personal use only $20.0 Sales Orders TCV (A$M) • Acquisition Date: 14 July 2020 • Acquisition cost: $35M $15.0 • Revenue at Acquisition: $8M • Single product – eUnity Diagnostic Viewer $10.0 • Previously
Slide 10: FY23 Highlights
For personal use only FY23 Highlights Record Sales Orders CARR3 ARR4 (TCV)1 Record Revenue $20.6M $17.0M run rate $40.3M $30.1M +$3.6M or 21% on PCP +$2.6M or 18% on PCP +$7.1M or 21% on PCP2 +$3.0M or 11% on PCP $24.8M at July 2023 $17.7M run rate July 2023 New contracts in EBITDA (adjusted)5 NPAT
Slide 11: Outlook
For personal use only Outlook Fragmentation Complex Renewal Sales pipeline opportunities opportunities opportunities opportunities • Fragmented imaging • More complex reading • Large FY24 renewal • Largest and most market with long-time environments and remote program will provide diverse pipeline o
Slide 12: Sales Overview
Sales Overview David Madaffri, COO For personal use only Issued 18 February 2021, approved by the Board 11 11
Slide 13: Our Solution – Enterprise Imaging Platform
Our Solution – Enterprise Imaging Platform Enterprise Data Management Enterprise Diagnostic Viewing Workflow Orchestration For personal use only Vendor Neutral Archive eUnity Enterprise Diagnostic Viewer Communication Workflow Engine ✓ Consolidate ALL Images across the enterprise ✓ Zero Footprint HT
Slide 14: Our Solution – Workflow Solutions
Our Solution – Workflow Solutions Quality Control Enterprise Worklists Viewer Mobility For personal use only Extending Radiology Tools to Enterprise Making Clinicians More Efficient Improving Clinician Collaboration ✓ Image Quality Control ✓ Provide Clinicians with Custom Worklists ✓ Allows Bedside
Slide 15: Mach7 Global Network - Scalability and Flexibility
Mach7 Global Network - Scalability and Flexibility More than 165 customers For personal use only spanning 15 countries Hospitals and healthcare entities around the world deploy Mach7’s solutions and innovative technologies. We have built a global network of diverse customers that range from expansiv
Slide 16: Customers and Partners
For personal use only Customers and Partners Partnerships focused on Meaningful Value to Support Patient Care Augmenting and expanding Mach7’s Enterprise Imaging Solution through innovative and collaborative partnerships designed to provide elevated value to healthcare providers around the globe. 15
Slide 17: Our Solution – Flexible Worklist Utilisation
For personal use only Our Solution – Flexible Worklist Utilisation Custom 16
Slide 18: Our Product Rankings
Our Product Rankings Best in KLAS 2023: Mach7 VNA For personal use only Universal Viewer Segment (Vendor Neutral Archive) Ranked alongside large legacy #2 Placed #2 overall PACS vendors by KLAS including for second year in a row GE, Agfa and Philips. #1 Held the #1 spot for V12 of the Mach7 VNA bein
Slide 19: Major Contract Wins
Major Contract Wins New customers expand geographic and sectoral footprint FY23 Highlights – New Customers Buy Entire Enterprise Imaging Platform: For personal use only • St. Paul’s Hospital HK - a private hospital with ~500 beds and more than 20 departments. The capital contract has TCV of $1.52M.
Slide 20: VNA Demonstration
VNA Demonstration Jeff Hastings, Technical For personal use only Sales Manager 19
Slide 21: Clinical Demonstration
Clinical Demonstration Kristi Creasey, Senior For personal use only Clinical Specialist 20 20
Slide 22: Questions
For personal use only Questions 21 21
Slide 23: Appendix
For personal use only Appendix 22 22
Slide 24: Our Markets
Our Markets Diverse Market Segments and Global Footprint For personal use only • Integrated Delivery Networks (IDNs) 165+ Customers in 15 Countries • US public health system (new market in FY24) • International hospital authorities • Regional and community hospital systems • Academic medical institu
Slide 25: Our Value Proposition
Our Value Proposition Fits Individual Needs Designed for the Enterprise Flexible Workflows For personal use only We can fit into customers’ existing The foundation is in the enterprise, not Flexibility of workflows – with an intuitive technology infrastructure or adapt as it individual departmental
Slide 26: KLAS – Defined
KLAS – Defined The Best in KLAS report recognises software and services companies who excel in helping healthcare professionals improve patient care. For personal use only KLAS surveys’ healthcare IT customers (providers) throughout Best in KLAS is highly competitive and the calendar year and releas
Slide 27: Our Revenue Model
Our Revenue Model Revenue model caters to client funding needs Flexible revenue model allows for both subscription (“SaaS”) and capital licences, generally on 5-year terms. For personal use only Equivalent Contracts: Capital Licence Subscription Licence Activity/Timing Fee Type Revenue Contribution
Slide 28: Mach7 University
For personal use only Mach7 University • Innovative solution to deliver training that fits work schedules and Course Catalog Examples lifestyles. • Clinical Studio Overview • eUnity 7.0 Overview • Unlimited attendees and unlimited access to informational videos, • eUnity Mammography • Hanging Protoc
Slide 29: Our Leadership Team
Our Leadership Team Mike Lampron Dyan O’Herne David Madaffri Ravi Krishnan Chief Executive Chief Financial Chief Operating General For personal use only Officer Officer Officer Manager, APAC Mike is the CEO of Mach7 Technologies. With over 20 years of Dyan is the Chief Financial Officer of Mach7 pri
Slide 30: Our Board of Directors
Our Board of Directors David Chambers Mike Lampron Philippe Houssiau Outgoing Non-Executive Managing Director Outgoing Non-Executive For personal use only Chairman Director David has more than 30 years’ extensive experience in the Healthcare and Life Science Mike is the Chief Executive Officer and M
Slide 31: Contact Us
For personal use only Contact Us Investor Relations, Mach7: Françoise Dixon +61 (0) 412 292 977 ir@mach7t.com Registered Office: Level 4 | 100 Albert Road, South Melbourne, VIC This document was authorised for release to the ASX by Mike Lampron, Managing Director and Chief Executive Officer Issued 1